HS 2918-16-00-90 – Other

Tariff data as of T2026-2, effective Sept 1, 2026, last verified Oct 21, 2026

Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives. › Gluconic acid, its salts and esters › Other

MFN duty rate

Free

GST

5%

Unit of measure

KGM

Other

Estimate duty & taxes · Get classification help

Preferential tariff rates

• Chile: Free
• Colombia: Free
• Norway (NT): Free
• Jordan (JT): Free
• Switzerland–Liechtenstein (SLT): Free
• Commonwealth Caribbean Countries Tariff (CCCT): Free
• CPTPP – United Kingdom (CPUKT): Free
• CETA: Free
• Ukraine: Free
• GPT: Free
• Panama (PAT): Free
• UST/CUSMA (US): Free
• Honduras (HNT): Free
• Costa Rica (CRT): Free
• CPTPP: Free
• Israel (CIAT): Free
• LDCT: Free
• Peru: Free
• Iceland: Free
• UK: Free
• MXT/CUSMA (Mexico): Free
• Korea: Free

Preference requires qualifying origin and origin proof or certification.

Frequently asked questions

What is the MFN duty on Other (HS 2918-16-00-90)?

The T2026-2 MFN rate for tariff item 2918.16.00 is Free. Specific or compound rates require manual calculation. Classification and origin must be verified with CBSA.

What is the duty on HS 2918-16-00-90 from the US?

Qualifying US-origin goods with origin proof use UST/CUSMA at Free. This item is not on any US surtax schedule in force in TariffPlus surtax data (checked against CBSA). GST/HST and any applicable personal-import provincial tax are additional.

Which trade agreement rates apply to HS 2918-16-00-90?

Chile: Free; Colombia: Free; Norway (NT): Free; Jordan (JT): Free; Switzerland–Liechtenstein (SLT): Free; Commonwealth Caribbean Countries Tariff (CCCT): Free; CPTPP – United Kingdom (CPUKT): Free; CETA: Free; Ukraine: Free; GPT: Free; Panama (PAT): Free; UST/CUSMA (US): Free; Honduras (HNT): Free; Costa Rica (CRT): Free; CPTPP: Free; Israel (CIAT): Free; LDCT: Free; Peru: Free; Iceland: Free; UK: Free; MXT/CUSMA (Mexico): Free; Korea: Free. Preferential treatment requires qualifying origin and certification. Rates are informational; CBSA is authoritative.